欧洲移民中的疫苗可预防疾病:一项系统综述
该系统综述检索了2010年1月至2024年4月间发表的文献,汇总了32个欧洲国家移民中疫苗可预防疾病的患病、发病、死亡及结局数据,共纳入57项研究、1950例病例。麻疹占50.8%、白喉占28.0%,超过60%病例疫苗接种史未知或未报告,报告5例死亡中4例为麻疹。作者认为移民因免疫空白面临更高风险,加强补种疫苗与数据收集是必要步骤。
要点
- 57项研究共报告1950例移民疫苗可预防疾病病例,麻疹占50.8%、白喉占28.0%。
- 超过60%病例疫苗接种史未知或未报告,报告5例死亡中4例为麻疹。
- 白喉主要影响青少年和成人,麻疹病例多为儿童。
核心结论
- 移民因疫苗接种缺口而面临较高的疫苗可预防疾病风险,加强补种疫苗(尤其针对青少年和成人)及改善数据收集是必要的后续步骤。
研究设计与样本
- 系统综述,检索Medline、Embase、Global Health及灰色文献,纳入2010年1月至2024年4月发表的32个欧洲国家移民(外国出生个体)疫苗可预防疾病原始研究与报告,采用Joanna Briggs Institute工具评估研究质量。
- 共纳入57项研究,报告16个国家1950例移民疫苗可预防疾病病例(2010—2024年)。
主要发现
- 报告病例包括麻疹992例(50.8%)、白喉546例(28.0%)、百日咳267例(13.7%)、流行性腮腺炎137例(7.0%),未报告风疹或破伤风病例。
- 来自希腊、德国和西班牙的6项研究共报告1942例病例(99.6%)。
- 白喉病例中超过一半(307例,55.4%)发生在接待中心;白喉主要影响青少年和成人(10项研究),麻疹病例多为儿童。
- 非欧盟/欧洲经济区欧洲移民(WHO EUR),主要来自波斯尼亚和黑塞哥维那及塞尔维亚,占麻疹病例的87%;非欧洲移民来自索马里(112例)、阿富汗(94例)、厄立特里亚(76例)和叙利亚(64例)。
- 超过60%病例的疫苗接种状态未知或未报告;报告5例疫苗可预防疾病相关死亡,其中4/5由麻疹导致。
临床怎么用
- 作者认为,加强补种疫苗接种(尤其针对青少年和成人)及改善数据收集是必要的后续步骤。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Migrants in Europe often face barriers to vaccination, increasing their vulnerability to vaccine-preventable diseases (VPDs). Despite policies promoting catch-up immunisation on arrival, data on VPD burden and outcomes among migrants remain limited. This systematic review synthesises evidence on the prevalence, incidence, mortality, and outcomes of VPDs in migrants across EU/EEA countries, UK, and Switzerland. METHODS: We searched Medline, Embase, Global Health, and grey literature sources (including websites of national public health organisations and agencies) for primary studies and reports on VPD cases among migrants (foreign-born individuals) in 32 European countries, published between January 2010 and April 2024. Data on demographics, VPD type, vaccination status, and outcomes were extracted. We focused on diphtheria, measles, mumps, pertussis, rubella, and tetanus. Study quality was assessed using Joanna Briggs Institute tools. RESULTS: Fifty-seven studies met inclusion criteria, reporting 1950 VPD cases in migrants across 16 countries (2010-2024). Most studies were in Germany (n = 12), Spain (n = 11), Switzerland (n = 8), Greece (n = 6), and the UK (n = 7). Reported cases included: measles (n = 992; 50.8 %), diphtheria (n = 546; 28.0 %), pertussis (n = 267; 13.7 %), and mumps (n = 137; 7.0 %). No cases of rubella or tetanus were reported. Migrants affected mainly included asylum seekers (n = 23 studies), refugees (n = 6), labour migrants (n = 2). Six studies from Greece, Germany, and Spain accounted for 1942 cases (99.6 %). Over half of diphtheria cases (n = 307; 55.4 %) occurred in reception centres. Diphtheria primarily affected adolescents and adults (n = 10 studies), while measles cases were mostly in children. Migrants from the Eastern Mediterranean and Africa were disproportionately affected by diphtheria. Non-EU/EEA European migrants (WHO EUR), mainly from Bosnia and Herzegovina and Serbia, accounted for most measles cases (87 %), and non-European migrants were from Somalia (n = 112), Afghanistan (n = 94), Eritrea (n = 76), and Syria (n = 64). Vaccination status was unknown or unreported in over 60 % of cases. Five VPD related deaths were reported of which 4/5 were due to measles. CONCLUSION: Migrants are at increased risk of VPDs due to gaps in vaccination. Strengthening catch-up vaccination, particularly in adolescents and adults, and improving data collection are essential next steps.
引用
- Halliday R, Morais B, Bouaddi O, et al. Vaccine-preventable diseases in migrants in Europe: a systematic review. Vaccine. 2025. PMID: 41056757. doi:10.1016/j.vaccine.2025.127788
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。